Cardiac surgery with extracorporeal circulation in cancer patients: Influence on surgical morbidity and mortality and on survival;Cirugía cardiaca con circulación extracorpórea en pacientes oncológicos: Influencia en la morbimortalidad quirúrgica y la supervivencia

Revista Espanola de Cardiologia

Volumn 61, Issue 4, 2008, Pages 369-375

  Carrascal, Yolanda ^a   Gualis, Javier ^a   Arévalo, Adolfo ^a   Fulquet, Enrique ^a   Flórez, Santiago ^a   Rey, Juvenal ^a   Echevarría, José R ^a   Di Stefano, Salvatore ^a   Fiz, Luis ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Cancer; Cardiac surgery; Extracorporeal circulation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW UP; GENDER; HEART LEFT VENTRICLE FAILURE; HEART SURGERY; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORTALITY; TUMOR RECURRENCE;

EID: 45249110690     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13117728     Document Type: Article

References (15)

1. Canver CC, Marrin CA, Pluma SK, Nugent WC. Should a patient with a treated cancer be offered an open heart operation? Ann Thorac Surg. 1993;55:1202-4.
2. Franchesca S, Frazier OH, Radovancevic B, De Caro LF, Reul G, Cooley D. Concomitant cardiac and pulmonary operations for lung cancer. Tex Heart Inst J. 1995;22:296-300.
3. Fecher AM, Birdas TJ, Haybron D, Papasavas PK, Evers D, Caushaj PF. Cardiac operations in patients with hematologic malignancies. Eur J Cardiothorac Surg. 2004;25:537-40.
4. Samuels LE, Kaufman MS, Morris RJ, Styler M, Brockman SK. Open heart surgery in patients with chronic lymphocytic leukaemia. Leuk Res. 1999;23:71-5.
5. Parsonnet V. Risk stratification in cardiac surgery: is it worthwhile? J Card Surg. 1995;10:690-8.
6. Mistiaen WP, Van Cauwelaert P, Muylaert P, Wuyts F, Harrison F, Bortier H. Effect of prior malignancy on survival after cardiac surgery. Ann Thorac Surg. 2004;77:1593-7.
7. Davydov MI, Akchurin RS, Gerasimov SS, Polotsky BE, Stilidi IS, Machaladze ZA, et al. Simultaneous operations in thoraco-abdominal clinical oncology. Eur J Cardiothorac Surg. 2001;20:1020-4.
8. Danton MH, Anikin VA, McMagnus KG, McGuigan JA, Campalani G. Simultaneous cardiac surgery with pulmonary resection: presentation of series and review of literature. Eur J Cardiothorac Surg. 1998;13:667-72.
9. Zacharski LR, Constantini V, Wojtukievicz MZ, Memoli VA, Kudryk BJ. Anticoagulants and cancer therapy. Semin Oncol. 1990;17:217-27.
10. Akchurin RS, Davidov MI, Partigulov SA, Brand JB, Shiriaev AA, Lepilin MG, et al. Cardiopulmonary bypass and cell-saver technique in combined oncologic and cardiovascular surgery. Artif Organs. 1997;21:763-5.
11. Christiansen S, Schmid C, Loher A, Scheld HH. Impact of malignant haematological disorders on cardiac surgery. Cardiovasc Surg. 2000;8:149-52.
12. Vaporciyan AA, Rice D, Correa AM, Walsh G, Putnam JB, Swisher S, et al. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur J Cardiothorac Surg. 2002;22:47-52.
13. Nurözler F, Kutlu T, Kücük G. Off-pump coronary bypass for patients with concomitant malignancy. Circ J. 2006;70:1048-51.
14. Ochi M, Yamada K, Fujii M, Ohkubo N, Ogasawara H, Tanaka S. Role of off-pump coronary artery bypass grafting in patients with malignant neoplastic disease. Jpn Circ J. 2000;64:13-7.
15. Francis JL, Amirkhosravi A. Effect of antihemostatic agents on experimental tumor dissemination. Semin Thromb Hemost. 2002;28:29-38.